Category Archives: News

PREVIEW-New obesity pills try to shed past problems

Posted on July 13, 2010 by

[Reuters] * First of three new obesity drugs up for review July 15 * Vivus’ Qnexa targets patients with related health issues * Arena, Orexigen seeking to sell rival drugs * Pills would be first for weight-loss in a decade … Continue reading →

Posted in News | Leave a comment

Avanafil Passes Second Late-Stage Test

Posted on June 7, 2010 by

Vivus (VVUS) shares had a bounce this morning by the encouraging announcement of round two of late-stage data on avanafil, a erectile dysfunction drug. Within 15 minutes of two doses, avanafil showed significant improvements of erectile function and intercourse from … Continue reading →

Posted in News | Tagged , , , , | Leave a comment

Data on VIVUS’ Qnexa to be Featured at World Congress Highlighting Metabolic Disease and Related Disorders

Posted on May 13, 2010 by

MOUNTAIN VIEW, Calif., May 13 /PRNewswire-FirstCall/ — VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa®, an investigational drug candidate, will be presented at the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) in Prague, Czech Republic. Timothy Garvey, … Continue reading →

Posted in News | Tagged , , , , | Leave a comment

Qnexa Suppresses Appetite, Lowers Blood Pressure in Study

Posted on May 5, 2010 by

By Denise Mann WebMD Health News// // ]]> May 4, 2010 (New York) — An experimental weight loss/blood pressure pill may pack a one-two punch against hunger and high blood pressure, one of the main health consequences of obesity, according to new … Continue reading →

Posted in News | Tagged , , , , , , , , , | Leave a comment

VIVUS Reports First Quarter 2010 Financial Results

Posted on May 3, 2010 by

// // // ]]> MOUNTAIN VIEW, Calif., May 3, 2010 /PRNewswire via COMTEX/ — VIVUS, Inc. (10.71, -0.04, -0.37%), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its highlights and financial results for the first quarter … Continue reading →

Posted in News | Tagged , , , , , , , , , | Leave a comment